Literature DB >> 9075093

A comparative study of nonoperative versus operative treatment of developmental dysplasia of the hip in patients of walking age.

S C Huang1, J H Wang.   

Abstract

We retrospectively reviewed our results of treatment of two groups of children with developmental dysplasia of the hip (DDH) aged between 13 and 17 months. The nonoperative group consisted of 16 patients (17 hips) who were treated by closed reduction and casting with or without skin traction. There were four hips with mild degrees of avascular necrosis, and one hip with a failed reduction. Before further treatment, there were one hip in Severin class I, nine in class III, six in class IV, and one in class VI. Subsequent open reduction or pelvic osteotomy was required in those hips with failed reduction and residual dysplasia. The operative group consisted of 32 patients (32 hips). Open reduction and Salter osteotomy were performed without preoperative traction. There was one hip with redislocation due to improper use of a short spica and two hips with a mild degree of avascular necrosis. In > 2 years and 3 months of follow-up, 13 hips were in Severin class I, 18 in class II, and one in class III. The treatment time was significantly shortened in the operative group. We conclude that neglected DDH in patients of walking age can be safely and effectively treated by open reduction plus Salter osteotomy.

Entities:  

Mesh:

Year:  1997        PMID: 9075093     DOI: 10.1097/00004694-199703000-00009

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  11 in total

Review 1.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Impact of Failed Pavlik Harness Treatment on the Outcomes Following Closed or Open Reduction in Developmental Dysplasia of the Hip.

Authors:  Yong Liu; Lisheng Kan; Jun Sun; Yapeng Zhang
Journal:  Indian J Orthop       Date:  2022-06-25       Impact factor: 1.033

3.  Effect of pelvic osteotomy in the skeletally immature on acetabular coverage.

Authors:  Sulaiman Al-Moussa; Paul Moroz; Paul E Beaulé
Journal:  HSS J       Date:  2012-09-21

4.  Treatment of developmental dysplasia of the hip (DDH) between the age of 18 and 24 months.

Authors:  Nabil Alassaf
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-21

5.  Closed reduction in late-detected developmental dysplasia of the hip: indications, results and complications.

Authors:  P Wicart; R Seringe; C Glorion; A Brassac; V Rampal
Journal:  J Child Orthop       Date:  2018-08-01       Impact factor: 1.548

6.  Comparing the Pemberton osteotomy and modified San Diego acetabuloplasty in developmental dysplasia of the hip.

Authors:  R Badrinath; J D Bomar; D R Wenger; S J Mubarak; V V Upasani
Journal:  J Child Orthop       Date:  2019-04-01       Impact factor: 1.548

7.  Narrative Review of Complications Following DDH Treatment.

Authors:  Raghav Badrinath; Caitlin Orner; James D Bomar; Vidyadhar V Upasani
Journal:  Indian J Orthop       Date:  2021-10-23       Impact factor: 1.251

Review 8.  Pelvic osteotomies in hip dysplasia: why, when and how?

Authors:  K Venkatadass; V Durga Prasad; Nasser Mohammed Mansor Al Ahmadi; S Rajasekaran
Journal:  EFORT Open Rev       Date:  2022-02-15

9.  An Unusual Complication Seen in a Six-Year-Old Girl Treated with Open Reduction and Pemberton Osteotomy for Neglected Developmental Dysplasia of the Hip: A Femoral Neck Fracture Sustained during Passive Motion under General Anesthesia.

Authors:  Vedat Uruc; Samet Karabulut
Journal:  Case Rep Orthop       Date:  2014-05-26

10.  Association between open or closed reduction and avascular necrosis in developmental dysplasia of the hip: A PRISMA-compliant meta-analysis of observational studies.

Authors:  Ya-Jie Wang; Fan Yang; Qi-Jun Wu; Shi-Nong Pan; Lian-Yong Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.